Insight Molecular Diagnostics (IMDX) Live Share Price, Invest From India

Insight Molecular Diagnostics Stock Performance

as on October 12, 2026 at 2:16 pm IST

Day's Low
Day's High
$3.19
Day's Price Range
$3.44
$3.37
5.34%
Downside
2.08%
Upside
52 Week's Low
52 Week's High
$2.42
52-Week Price Range
$8.51
$3.37
28.19%
Downside
152.52%
Upside

Insight Molecular Diagnostics share price movements today

Previous Close: $3.28
Open: $3.44
Volume: 356.0K
Market Cap: $110.3M
Day's Low - High: $3.19 - $3.44
52 Week Low - High: $2.42 - $8.51

Insight Molecular Diagnostics Historical Returns

1 Month Return: -19.76 %
3 Month Return: -33.66 %
1 Year Return: -13.37 %
3 Year Return: 0 %
5 Year Return: 0 %

Insight Molecular Diagnostics Stock Fundamentals & Key Indicators

Check Insight Molecular Diagnostics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$110.3M

EPS (TTM)

-1.52

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.22

Industry PE ratio

-2.76

PEG Ratio

-0.03

EBITDA

-46.8M

Revenue (TTM)

1.7M

Profit Margin

11.17%

Return On Equity TTM

271.76%

Insight Molecular Diagnostics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Insight Molecular Diagnostics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Insight Molecular Diagnostics	Buy	$110.3M	NA	-2.22	11.17%	0.00%
Natera	StrongBuy	$57.8B	268.00%	-294.64	65.30%	0.00%
Agilent	StrongBuy	$48.1B	15.27%	33.50	53.73%	0.60%
Thermo Fisher	StrongBuy	$243.3B	14.26%	35.34	41.03%	0.28%
Danaher	StrongBuy	$154.5B	-25.95%	38.92	58.51%	0.69%

Stock Returns calculator for Insight Molecular Diagnostics Stock including INR - Dollar returns

The Insight Molecular Diagnostics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Insight Molecular Diagnostics investment value today

Current value as on today

₹93,565

Returns

-₹6,435

(-6.44%)

Returns from Insight Molecular Diagnostics Stock

-₹13,368 (-13.37%)

Dollar Impact

₹6,932 (+6.93%)

Analyst Recommendation on Insight Molecular Diagnostics Stock

Based on 3 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Insight Molecular Diagnostics. Average target price of $10.5

Insight Molecular Diagnostics Share Price Target

Get share price movements and forecasts by analysts on Insight Molecular Diagnostics.

Current Price

$3.37

Analyzed by

3 Analysts

High

$12

Low

Insight Molecular Diagnostics target price $0, a slight upside of 0% compared to current price of $3.37. According to 3 analysts rating.

Indian Investors' Interest in Insight Molecular Diagnostics Stock

Search interest for Insight Molecular Diagnostics Stock has decreased by -54% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 12, 2026 to October 12, 2026

Change:-54% versus previous 30 day period

Insight Molecular Diagnostics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	0	0	0	1	2	0	0	1	0	0
Gross Profit	0	0	0	0	1	0	0	0	0	0
Operating Income	-9	-4	-13	-33	-6	-9	-11	-9	-10	-11
EBITDA	-8	-4	-13	-32	-6	-9	-10	-22	-3	-10
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-9	-4	-13	-33	-6	-9	-10	-22	-4	-11
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-9	-4	-13	-33	-6	-9	-10	-22	-4	-11
Net Profit Margin	25.57%	48.08%	43.48%	40.04%	61.97%	67.57%	53.46%	43.55%	-1892.19%	65.69%

Insight Molecular Diagnostics Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Mar 2019	Dec 2019	Dec 2020	Dec 2021	Mar 2023	Mar 2024	Dec 2024	Dec 2025
Total Revenue	-	-	-	1	2	0	1	1	4
Gross Profit	0	0	0	0	1	0	0	0	0
Operating Income	-18	-15	-22	-29	-53	-17	-25	-61	-30
EBITDA	-18	-15	-21	-30	-48	-13	-23	-59	-47
Interest Expense	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	4	5	1	1	2
Income Before Tax	-19	-15	-22	-31	-52	-18	-24	-60	-50
Income Tax Expense	-	-	-	-1	-9	-	-	-	-
Net Income	-19	-15	-22	-29	-64	-72	-27	-60	-50
Net Profit Margin	0.00%	0.00%	0.00%	-52.55%	64.60%	-1.88%	27.48%	39.34%	4.69%

Insight Molecular Diagnostics Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-9	-4	-13	-33	-6	-9	-10	-22	-4	-11
Operating Cash Flow	-3	-5	-5	-5	-5	-6	-4	-5	-7	-9
Investing Cash Flow	0	0	0	0	0	0	-1	-1	0	0
Financing Cash Flow	-	9	0	10	28	0	0	0	24	0
Change in Cash	-3	3	-5	5	22	-6	-5	-7	16	-10

Insight Molecular Diagnostics Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Mar 2019	Dec 2019	Dec 2020	Dec 2021	Mar 2023	Mar 2024	Dec 2024	Dec 2025
Net Income	-19	-15	-22	-29	-64	-72	-27	-60	-50
Operating Cash Flow	-13	-11	-19	-25	-35	-45	-23	-20	-22
Investing Cash Flow	0	0	-12	-11	-13	-4	0	0	-3
Financing Cash Flow	9	12	47	22	78	35	12	20	28
Change in Cash	-2	0	15	-14	28	-14	-12	0	3

Global Institutional Holdings in Insight Molecular Diagnostics

Check out the Institutions with significant holdings in Insight Molecular Diagnostics.

Funds	Holdings
Vanguard	2.21%
VANGUARD INDEX FUNDS	1.62%
Fidelity Concord Street Trust	0.60%
iShares	0.13%
VANGUARD VALLEY FORGE FUNDS	0.02%

See all

Insights on Insight Molecular Diagnostics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 32.0K → 239.0K (in $), with an average increase of 86.6% per quarter
NO EFFECT
Against Peers
In the last 3 years, Natera, Inc. Common Stock has given 917.3% return, outperforming this stock by 916.7%
NO EFFECT
Against Peers
In the last 1 year, Natera, Inc. Common Stock has given 136.7% return, outperforming this stock by 150.1%
NEGATIVE IMPACT
Price Dip
In the last 7 days, IMDX stock has moved down by -8.2%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -4.29M → -11.26M (in $), with an average decrease of 162.5% per quarter

About Insight Molecular Diagnostics

OncoCyte Corporation functions as a molecular diagnostics firm specializing in the research, development, and market introduction of distinctive, laboratory-developed tests aimed at cancer identification. Its operations span both the United States and international territories. The company's key offerings include DetermaRx, a molecular diagnostic tool tailored for detecting early-stage adenocarcinoma of the lung, and DetermaIO, a proprietary gene expression analysis. Additionally, OncoCyte provides a range of expert services, such as biomarker discovery, assay design and refinement, and clinical trial assistance, which encompass offering various biomarker tests to pharmaceutical partners. A strategic partnership with Life Technologies Corporation focuses on the collaborative development and commercialization of the Oncomine Comprehensive Assay Plus and Determa IO assay, intended for integration with the Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was founded in 2009 and maintains its principal office in Irvine, California.

Organisation	Insight Molecular Diagnostics
Headquarters	2 International Plaza Dr., Nashville, TN, 37217, US
Industry	Medical - Diagnostics & Research
CEO	Joshua Riggs

Key Management of Insight Molecular Diagnostics

Name	Title
Mr. Peter Hong	VP, General Counsel & Secretary
Mr. Steven Tahmooressi	Vice President of Marketing
Mr. Joshua Riggs	President, CEO & Director
Dr. Ekkehard Schutz M.D., Ph.D.	Chief Science Officer
Mr. Yuh-Min Chiang Ph.D.	Chief Technology Officer
Donnie Purto	SVP of Sales & Sales Operations
Ms. Sandra O'Donald	Senior Vice President of Business Operations
Dr. Paul R. Billings FACP, M.D., Ph.D.	Consulting Chief Medical Officer
Ms. Andrea Susan James	Chief Financial Officer
Mr. James Liu	VP of Accounting, Treasurer, Controller & Principal Accounting Officer

FAQs

What is Insight Molecular Diagnostics share price today?

Insight Molecular Diagnostics share price today is $3.37 as on October 12, 2026 at 8:46 am IST at the close of the market. Insight Molecular Diagnostics share today touched a day high of $3.44 and a low of $3.19.

What is the 52 week high and 52 week low for Insight Molecular Diagnostics share?

Insight Molecular Diagnostics share touched a 52 week high of $8.51 on November 12, 2025 and a 52 week low of $2.42 on March 31, 2026. Insight Molecular Diagnostics stock price today i.e. October 12, 2026 at 8:46 am IST is closed at $3.37,which is 60.40% down from its 52 week high and 39.26% up from its 52 week low.

What is Insight Molecular Diagnostics's market capitalisation today?

Insight Molecular Diagnostics market capitalisation is $0.00T as on October 12, 2026 at 8:46 am IST.

How to invest in Insight Molecular Diagnostics Stock (IMDX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Insight Molecular Diagnostics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Insight Molecular Diagnostics Stock (IMDX) from India?

Indian investors can start investing in Insight Molecular Diagnostics (IMDX) shares with as little as ₹95.76000213623047 or $1 (as of October 12, 2026 at 6:48 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.60 in Insight Molecular Diagnostics stock (as per the Rupee-Dollar exchange rate as on October 12, 2026 at 6:48 pm IST). Based on Insight Molecular Diagnostics share’s latest price of $3.37 as on October 12, 2026 at 8:46 am IST, you will get 2.9674 shares of Insight Molecular Diagnostics. Learn more about fractional shares .